Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
May 12, 2006 | VP - Clin. Dev. & Med. Affairs | Form 4 | Open market or private purchase of non-derivative or derivative security | 300 | $3.75 | 2,300 | |
May 12, 2006 | VP - Clin. Dev. & Med. Affairs | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,700 | $3.75 | 4,000 | |
November 15, 2013 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,000 | $3.80 | 14,331 | |
March 14, 2014 | Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $3.84 | 57,521 | |
March 14, 2014 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,500 | $3.86 | 21,331 | |
May 13, 2009 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 15,000 | $3.90 | 137,562 | |
May 7, 2010 | President & CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $3.95 | 126,662 | |
March 17, 2006 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,000 | $4.03 | 70,800 | |
March 14, 2006 | VP - Clin. Dev. & Med. Affairs | Form 4/A | Open market or private purchase of non-derivative or derivative security | 200 | $4.05 | 200 | |
March 14, 2006 | VP - Clin. Dev. & Med. Affairs | Form 4/A | Open market or private purchase of non-derivative or derivative security | 800 | $4.05 | 1,000 | |
March 14, 2006 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 200 | $4.05 | 200 | |
March 14, 2006 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 800 | $4.05 | 1,000 | |
June 18, 2008 | VP & Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,000 | $4.10 | 8,000 | |
March 20, 2006 | VP - Clin. Dev. & Med. Affairs | Form 4 | Open market or private purchase of non-derivative or derivative security | 200 | $4.19 | 2,000 | |
March 20, 2006 | VP - Clin. Dev. & Med. Affairs | Form 4 | Open market or private purchase of non-derivative or derivative security | 800 | $4.20 | 1,800 | |
September 20, 2012 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,735 | $4.22 | 366,385 | |
September 20, 2012 | Director | Form 4 | Exercise of in-the-money or at-the-money derivative security | 18,735 | $4.22 | -- | |
July 25, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 46,838 | $4.27 | 243,942 | |
July 25, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 18,735 | $4.27 | 70,360 | |
March 3, 2006 | EVP, CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,500 | $4.28 | 17,944 | |
June 16, 2008 | Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 400 | $4.38 | 27,067 | |
June 16, 2008 | Director, President & CEO | Form 4/A | Open market or private purchase of non-derivative or derivative security | 400 | $4.38 | 27,067 | |
June 16, 2008 | Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 300 | $4.39 | 27,367 | |
June 16, 2008 | Director, President & CEO | Form 4/A | Open market or private purchase of non-derivative or derivative security | 300 | $4.39 | 27,367 | |
June 16, 2008 | Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,800 | $4.40 | 29,167 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.